We are live on ! Find out more
CPX

Canaan Partners X Portfolio holdings

AUM $74.7M
1-Year Est. Return 151.56%
This Fund
S&P 500
This Quarter Est. Return
-25.79%
1 Year Est. Return
+151.56%
3 Year Est. Return
+55.41%
5 Year Est. Return
10 Year Est. Return
AUM
$50.3M
AUM Growth
-$33.1M
Cap. Flow
-$3.25M
Cap. Flow %
-6.46%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
NXTC icon
NextCure
NXTC
+$3.25M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDYA icon
1
IDEAYA Biosciences
IDYA
$3.54B
$33.4M 66.44%
2,660,713
NXTC icon
2
NextCure
NXTC
$20.8M
$15.1M 29.94%
142,626
-26,411
-16% -$3.25M
ITRM
3
DELISTED
Iterum Therapeutics
ITRM
$1.82M 3.62%
115,545

Similar funds

Canaan Partners X's Q3 2020 Portfolio in Review

As of Q3 2020, Canaan Partners X held 3 positions worth $50.3M, down 40% from $83.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Canaan Partners X withdrew a net $3.25M in Q3 2020, reducing 1 holding. Its largest reduction was NextCure, cutting an estimated $3.25M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Canaan Partners X's biggest Q3 2020 reduction was NextCure, cutting an estimated $3.25M.
  • Canaan Partners X's ten largest holdings make up 100% of its $50.3M portfolio in Q3 2020.
  • Canaan Partners X opened 0 new positions and closed 0 in Q3 2020.
  • Canaan Partners X's portfolio value fell 40% quarter-over-quarter to $50.3M.

Based on Canaan Partners X's 13F filing for Q3 2020, filed 26 Oct 2020.